Optimization strategies for HPLC enantioseparation of racemic drugs using polysaccharides and macrocyclic glycopeptide antibiotic chiral stationary phases.
about
Evolving neural network optimization of cholesteryl ester separation by reversed-phase HPLC.Enantio-separation of drugs with multiple chiral centers by chromatography and capillary electrophoresis.Chiral separation of quinolones by liquid chromatography and capillary electrophoresis.Direct enantiomeric resolution of betaxolol with application to analysis of pharmaceutical products.Enantiomeric resolution and modeling of DL-alanine-DL-tryptophan dipeptide on amylose stationary phase.Stereoselective HPLC analysis of tertatolol in rat plasma using macrocyclic antibiotic chiral stationary phase.Chemical chiral pollution: Impact on the society and science and need of the regulations in the 21st century.Chiral separation and modeling of baclofen, bupropion, and etodolac profens on amylose reversed phase chiral column.Fast Screening of Whole Blood Samples and Pharmaceutical Compounds for Enantiorecognition of Free L-T3 , L-T4 , and D-T4.Enantioselective HPLC analysis and biodegradation of atenolol, metoprolol and fluoxetineChiral HPLC Separation and Modeling of Four Stereomers of DL-Leucine-DL-Tryptophan Dipeptide on Amylose Chiral ColumnChiral resolution of multichiral center racemates by different modalities of chromatographyEnantiomeric resolution and simulation studies of four enantiomers of 5-bromo-3-ethyl-3-(4-nitrophenyl)-piperidine-2,6-dione on a Chiralpak IA column
P2860
Q33956701-D685AE87-0BB8-499E-B076-9884652FCFC2Q35213968-E17CA5FC-38C4-438F-B3C2-25EBCC9C6EBAQ39311454-29AF8153-1235-43CC-9F01-0ED5D0BB8BC1Q42076975-0A48114C-542E-4445-AD02-B4BC9921A6AFQ47189460-2B03AD8C-ACFA-40FC-8E14-8A17B8C4ECB6Q47254883-ED53A839-3112-45D9-8BCD-5B2FFD6EA5E0Q47269208-7350D933-0172-46E5-B3CE-D40C400CA18EQ48007359-D1F834D9-9474-4982-968F-79E8CB26B1E0Q53787034-14430FF1-221C-45FF-9D9E-8FEB19982EB6Q58875575-24B8054A-C092-43DF-A679-4D5A3A9CE245Q59150020-1FD68D58-4879-403B-8A41-ADD4E16B147FQ59150021-00DD227A-679C-45A3-8B20-757BBE4B0B3FQ59150022-C734ABE8-433D-4A74-904F-A8210DE1D016
P2860
Optimization strategies for HPLC enantioseparation of racemic drugs using polysaccharides and macrocyclic glycopeptide antibiotic chiral stationary phases.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Optimization strategies for HP ...... otic chiral stationary phases.
@ast
Optimization strategies for HP ...... otic chiral stationary phases.
@en
Optimization strategies for HP ...... otic chiral stationary phases.
@nl
type
label
Optimization strategies for HP ...... otic chiral stationary phases.
@ast
Optimization strategies for HP ...... otic chiral stationary phases.
@en
Optimization strategies for HP ...... otic chiral stationary phases.
@nl
prefLabel
Optimization strategies for HP ...... otic chiral stationary phases.
@ast
Optimization strategies for HP ...... otic chiral stationary phases.
@en
Optimization strategies for HP ...... otic chiral stationary phases.
@nl
P1433
P1476
Optimization strategies for HP ...... iotic chiral stationary phases
@en
P2093
Hassan Y Aboul-Enein
P304
P356
10.1016/S0014-827X(02)01242-9
P50
P577
2002-07-01T00:00:00Z